Degarelix (Subcutaneous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Degarelix (Subcutaneous Route)

Drug Information provided by: Micromedex

Description

Degarelix is used in men to treat advanced prostate cancer. Degarelix is a type of medicine called a gonadotropin-releasing hormone (GnRH) antagonist. It helps treat prostate cancer by lowering the amount of testosterone hormone in the blood. In some patients, testosterone will cause prostate cancer to grow larger.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Powder for Solution
Before Using
DR602863 Portions of this document last updated: July 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger